4.6000
+0.4200
+(10.05%)
At close: April 11 at 4:00:01 PM EDT
4.6199
+0.02
+(0.43%)
After hours: April 11 at 7:54:56 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.36 | -0.36 | 0.03 | -0.62 |
| Low Estimate | -0.39 | -0.43 | -1.3 | -1.3 |
| High Estimate | -0.33 | -0.3 | 1.42 | -0.13 |
| Year Ago EPS | -0.52 | -0.44 | -1.53 | 0.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 6 | 6 |
| Avg. Estimate | -- | -- | 12.28M | 78.6M |
| Low Estimate | -- | -- | 9M | 57M |
| High Estimate | -- | -- | 15M | 106.5M |
| Year Ago Sales | -- | -- | -- | 12.28M |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 539.90% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.53 | -0.34 | -0.41 | -0.34 |
| EPS Actual | -0.52 | -0.44 | -0.31 | -0.32 |
| Difference | 0.01 | -0.1 | 0.1 | 0.03 |
| Surprise % | 1.38% | -28.79% | 24.27% | 7.99% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.36 | -0.36 | 0.03 | -0.62 |
| 7 Days Ago | -0.37 | -0.36 | -0.43 | -0.69 |
| 30 Days Ago | -0.38 | -0.38 | -0.39 | -0.09 |
| 60 Days Ago | -0.38 | -0.36 | -1.12 | -0.09 |
| 90 Days Ago | -0.38 | -0.36 | -1.12 | -0.09 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | -- |
| Up Last 30 Days | 1 | -- | -- | -- |
| Down Last 7 Days | 1 | 2 | 1 | 1 |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABEO | 31.13% | 17.79% | 102.12% | -1,997.45% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Initiated | Oppenheimer: Outperform | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/19/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/31/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/29/2024 |
Related Tickers
MIST Milestone Pharmaceuticals Inc.
0.7713
+2.84%
ALDX Aldeyra Therapeutics, Inc.
1.9100
+1.06%
ATRA Atara Biotherapeutics, Inc.
5.53
+4.34%
KALV KalVista Pharmaceuticals, Inc.
11.49
+9.01%
GRCE Grace Therapeutics, Inc.
1.9799
+1.02%
UNCY Unicycive Therapeutics, Inc.
0.5476
+3.30%
NUVB Nuvation Bio Inc.
1.9900
+13.71%
SCPH scPharmaceuticals Inc.
2.3200
+15.14%
FDMT 4D Molecular Therapeutics, Inc.
2.6300
+1.54%
LXEO Lexeo Therapeutics, Inc.
1.9800
-8.76%